The National Institute of Allergy and Infectious Diseases (NIAID), Vaccine Research Center (VRC) intends to negotiate on an other than full and open competition basis with Illumina Inc., 5200 Illumina Way, San Diego, CA 92122-4616 to procure NovaSeq 6000 equipment. This acquisition will be processed under FAR Part 12 - Acquisition for Commercial Items and will be made pursuant to the authority in FAR Part 13.501(a)(1).

Only one award will be made as a result of this solicitation. This will be awarded as a firm fixed price type of contract.

The additional Illumina Inc., equipment will expand NIAID's sequencer capabilities. This expanded capability is required to keep up with the ever increasing research efforts. This expansion will allow for additional laboratory sequencing techniques not otherwise possible. System expansion must utilize the same equipment and software to maintain continuity and data integrity between NIAID laboratories. Equipment can only be provided by Illumina Inc..

The statutory authority for this sole source requirement is 41 U.S.C. 253 (c) (1) as implemented by FAR 6.302-1 only one source available, no substitutions possible, and equipment must be compatible with existing equipment. THIS IS NOT A SOLICITATION FOR COMPETITIVE QUOTATIONS. All responsible sources who can provide the same or similar equipment may submit a response that could be considered by email to Brad Engel at [email protected] by the specified date/time of this notice. All information furnished must be in writing and must contain sufficient detail to allow NIAID to determine if it can meet the above unique specifications described herein. All responses received by the closing date of this solicitation will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.

Bid Protests Not Available